With offices in Singapore, Shanghai, and Mumbai, Novo Holdings Asia was established to invest in the large and attractive life sciences market in the region. We support healthcare companies across the continent, with a tailored approach to accommodate regional differences, participating across company life cycles and modalities including public equities, minority investments, co-investments, and buyouts.
Our Asia operations
Our investments in Asia
In Asia, we are committed to identifying and investing in life science and healthcare companies that are leading innovators in their field. Our investments cover a range of healthcare subsectors, including medtech, life sciences tools and diagnostics, pharma services, healthcare IT, patient services, and greentech.
"Novo Holdings' Asia operations are a testament to our commitment to this dynamic region with a fast-growing life science sector. We are focused on investing around innovation in human and planetary health, and supporting healthcare solutions that are accessible and affordable."
Amit Kakar
Managing Partner, Head of Novo Holdings Asia
Our people in Asia
Meet the team leading our investments and operations in Asia.